460. SARS-CoV-2 Infection-Induced Antibody Seroprevalence in Previously Infected Persons with Immunocompromising Conditions — United States, 2020–2022

BACKGROUND: People with immunocompromising conditions (IC) are at increased risk of severe COVID-19 and death. These individuals show weaker immunogenicity following vaccination than individuals without IC, yet immunogenicity after SARS-CoV-2 infection is poorly understood. To address this gap, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bratcher, Anna, Jones, Jefferson M, Harris, Aaron, Clarke, Kristie E N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677318/
http://dx.doi.org/10.1093/ofid/ofad500.530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677318/
http://dx.doi.org/10.1093/ofid/ofad500.530

Ejemplares similares